| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.083 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |